| Systematic (IUPAC) name | |
|---|---|
| 4-(1-naphthalen- 1-ylethyl)- 1H-imidazole | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 137967-81-8 |
| ATC code | ? |
| PubChem | CID 132110 |
| ChemSpider | 24531958 |
| Chemical data | |
| Formula | C15H14N2 |
| Mol. mass | 222.285 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
4-NEMD is a potent sedative drug which acts as a selective alpha-2 adrenergic agonist. It is closely related to dexmedetomidine but is several times more potent.[1] Like other alpha-2 agonists, it produces sedative and muscle relaxant effects but without producing respiratory depression. It is not currently used in medicine but has been researched as the basis for a potential new generation of alpha-2 agonist drugs,[2][3] which may have selectivity for the different subtypes of the alpha-2 receptor.[4] It has two isomers, with the (S) isomer being the more potent, as with medetomidine.[5] 4-NEMD was also investigated by the United States military as an anaesthetic agent, most likely for use in surgery but possibly also for use as a non-lethal incapacitating agent.[6]
|
|||||||||||||||||||||||||||||
| This sedative-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)